North American Injection Pen Market Size, Share & Trends Analysis Report by Type (Reusable and Disposable), by Disorder Type (Autoimmune Disorder, Hormonal Disorders, Orphan Disease, and Others), and Forecast 2020-2026.
The North American injection pen market is projected to grow at a CAGR of 6.2% during the forecast period (2020-2026). The market growth in North America is attributed to the rising incidences of various diseases such as autoimmune disorders, hormonal disorders, and several other diseases. The changing eating habits, sedentary lifestyle, and obesity problems are some of the major factors causing these diseases amongst the people in the region.
Owing to increase incidences of diseases due to obesity problems, there is a significant demand for treatment options across the region. For instance, in the region, the prevalence of diabetes is approximately 13.3% of the total adult population which is expected to increase in the near future. Hence, for an increased number of patient pools, there is likely to be an increase in the demand for insulin pens, which in turn, will drive the growth of the market.
The North American injection pen market is segmented on the basis of type, and disorder type. Based on the type, the market is bifurcated into reusable and disposable. Most of the injectors available today are reusable as these require the replacement of only needles and cartridges. In addition, these can be used for a longer time, which makes them cost-effective. Based on the disorder type, the market is segmented into autoimmune disease, hormonal disorders, orphan disease, and others. The autoimmune disorder which includes diabetes and arthritis is a major application for an injection pen.
Geographically, the North American injection pen market is segmented into the US and Canada. The US is anticipated to dominate the market and will continue this trend over the forecast period. Further, Eli Lily & Co., Pfizer Inc., Becton, Dickinson & Co., AstraZeneca Plc, and Novo Nordisk A/S are some of the prominent players operating in the North American injection pen market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.
Research Methodology
The market study of the North American injection pen market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.
Secondary Sources Include:
Market Segmentation:
1. North America Injection Pen Market Research and Analysis by Type
2. North America Injection Pen Market Research and Analysis by Disorder Type
The Report Covers:
The North American injection pen market is projected to grow at a CAGR of 6.2% during the forecast period (2020-2026). The market growth in North America is attributed to the rising incidences of various diseases such as autoimmune disorders, hormonal disorders, and several other diseases. The changing eating habits, sedentary lifestyle, and obesity problems are some of the major factors causing these diseases amongst the people in the region.
Owing to increase incidences of diseases due to obesity problems, there is a significant demand for treatment options across the region. For instance, in the region, the prevalence of diabetes is approximately 13.3% of the total adult population which is expected to increase in the near future. Hence, for an increased number of patient pools, there is likely to be an increase in the demand for insulin pens, which in turn, will drive the growth of the market.
The North American injection pen market is segmented on the basis of type, and disorder type. Based on the type, the market is bifurcated into reusable and disposable. Most of the injectors available today are reusable as these require the replacement of only needles and cartridges. In addition, these can be used for a longer time, which makes them cost-effective. Based on the disorder type, the market is segmented into autoimmune disease, hormonal disorders, orphan disease, and others. The autoimmune disorder which includes diabetes and arthritis is a major application for an injection pen.
Geographically, the North American injection pen market is segmented into the US and Canada. The US is anticipated to dominate the market and will continue this trend over the forecast period. Further, Eli Lily & Co., Pfizer Inc., Becton, Dickinson & Co., AstraZeneca Plc, and Novo Nordisk A/S are some of the prominent players operating in the North American injection pen market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.
Research Methodology
The market study of the North American injection pen market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.
Secondary Sources Include:
- Financial reports of companies involved in the market
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
Market Segmentation:
1. North America Injection Pen Market Research and Analysis by Type
2. North America Injection Pen Market Research and Analysis by Disorder Type
The Report Covers:
- Comprehensive research methodology of the North American injection pen market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American Injection pen market.
- Insights about market determinants which are stimulating the North American injection pen market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of the market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Market Determinants
4. Market Segmentation
5. Regional Analysis
6. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- AstraZeneca Plc
- Becton, Dickinson & Co.
- Copernicus
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Gerresheimer AG
- GlaxoSmithKline Plc
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
